Whose skin conditions require special considerations: women or men?

Women and men are not always created equal when it comes to their dermatologic concerns, frequency and presentation of several dermatologic conditions, treatment options and outcomes.
» Full article

Healthcare reform requires novel approaches to patient care

To meet Affordable Care Act goals regarding patient access and quality of care, an expert says, dermatologists are finding increasingly creative ways to deliver care where it’s needed.
» Full article

Treating psoriasis using biologic agents: what are your colleagues doing?

As the use of therapy for moderate-to-severe psoriasis grows, an expert says, physicians continue refining treatment strategies.
» Full article

Many potential indications for botulinum toxin formulations have yet to be realized

The emergence of new formulations of botulinum toxin and other neuromodulators in the pipeline awaiting approval by the Food and Drug Administration signal a need for clinicians to stay abreast of the various uses and potential adverse events. » Full article

Targeted therapy, immunotherapy tackle metastatic melanoma

There has been a rapid revolution in the treatment of metastatic melanoma since the identification of driver oncogenes such as BRAF and its mutations more than a decade ago, according to a clinical researcher at the Vanderbilt-Ingram Cancer Center, Nashville, Tenn. » Full article

Downloads

You are subscribed to the Dermatology Times Issue Alert.

• Curbside consultations have value

• Financial contract must-haves

• Best practices of isotretinoin

• PD-1, PD-L1 pathway inhibition represent melanoma treatment strategy